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Prevalence of and risk factors for FIV and FeLV infection in cats in two shelters in the United 
Kingdom (2011-2012) 
Abstract 1 
The aims of this study were to determine the prevalence of FeLV and FIV infection in cats 2 
presented to two RSPCA animal rehoming centres and to identify risk factors for infection. 3 
All cats presented at each centre between August 2011-August 2012 were subjected to a 4 
patient-side test for FeLV/FIV on entry. Kittens under 3 months and cats euthanased within a 5 
short time of presentation were excluded from the study. Univariable and multivariable logistic 6 
regression were used to separately determine risk factors for FeLV and FIV infection. 7 
At shelter A, the prevalence of FIV infection was 11.4% (54/474) and FeLV infection was 3% (14/473), 8 
with two FIV/FeLV co-infections identified. At shelter B, the prevalence of FIV infection was 3% 9 
(4/135) and FeLV infection was 0% (0/135). Cats at shelter A were significantly more likely than 10 
those at shelter B to test positive for FIV (P = 0.0024) and FeLV (P = 0.048). Male cats were more 11 
likely to be infected with FIV (OR 27.1, p=0.001), and thin body condition and musculoskeletal 12 
disease were associated with risk of FeLV. Overall, FIV and FeLV positive cats were significantly 13 
older (median ages 5.1 and 4.75 years respectively) than the uninfected populations (median 14 
ages 3.4 and 3.5 years respectively).  15 
This study shows that the prevalence of these diseases varies between shelter populations. 16 
Local knowledge combined with the risk factors identified may be useful in focussing resources 17 
for population testing strategies.  18 
  19 
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Introduction 20 
Feline immunodeficiency virus (FIV) and feline leukaemia virus (FeLV) are diseases of domestic 21 
cats and related species. FIV is commonly spread by fighting and biting (blood-to-blood contact), 22 
although sexual and vertical transmission are also possible (Hartmann 2011). Once acquired, 23 
FIV infection is lifelong, and there is no known recovery or cure (Hartmann 2012).  24 
FeLV is considered to be a “friendly cat” disease, with transmission by mutual grooming and 25 
sharing of food and water bowls considered to be the most prominent routes of transmission, 26 
although transmission by fighting and biting may also occur (Cattori and others 2009; Francis 27 
and others 1977; Hartmann 2011, 2012). Exposure may result in a variety of outcomes, including  28 
abortive, regressive and progressive infection. If a sufficient humoral and cell-mediate immune 29 
response is mounted, the virus will be eliminated, termed “abortive infection”. However, it has 30 
become clear that apparently “recovered”, antigen-negative cats may retain proviral DNA in bone 31 
marrow progenitor cells (Lutz and others 2009; Major and others 2010). Such cats, termed 32 
“regressively infected” will test negative for circulating antigen and are at low risk of FeLV-33 
associated disease. Some studies have suggested that regressively infected cats may be at 34 
increased risk of FeLV-associated disease such as lymphoma and anaemia; however others 35 
have not found a link, and the potential role of FeLV in such circumstances is as yet unclear 36 
(Gabor and others 2001a; Jackson and others 1993; Stützer and others 2011). It has also been 37 
shown that regressive cats can be a source of FeLV infection via blood transfusion (Nesina and 38 
others 2015). Progressive FeLV infection occurs when there is an inadequate immune response 39 
and a permanent viraemia results, with affected cats typically dying of FeLV-associated disease 40 
including lymphoma or aplastic anaemia within three years of infection (Hartmann 2012). 41 
Within domestic cat populations, prevalence of these two viruses is variable. Male gender,  42 
outdoor access, a history of aggressive behaviour or fight wounds and evidence of ill-health on 43 
presentation have been consistently associated with increased risk of both diseases (Bande and 44 
others 2012a; Gleich and others 2009b; Hosie and others 1989; Levy and others 2006; Malik and 45 
others 1997; Muirden 2002). A variety of clinical presentations have been linked with increased 46 
risk of infection, with gingivitis linked most consistently with FIV (Bande and others 2012b; Gleich 47 
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and others 2009a; Goldkamp and others 2008; Yilmaz and others 2000), and anaemia with FeLV 48 
(Hosie and others 1989). Both FIV and FeLV have been linked with an increased risk of 49 
neoplasia, particularly lymphomas (Gabor and others 2001a; Gabor and others 2001b). As both 50 
diseases can cause immunosuppression and reduced immunosurveillance, recurrent or 51 
recalcitrant presentations of common diseases such as feline upper respiratory tract infection  52 
(“cat flu”) have also been suggested to be potential indicators of infection (Hartmann 2012; 53 
Yamamoto and others 1989).  Adult cats have been identified as being at greater risk than 54 
juveniles for FIV, probably due to greater cumulative opportunities to perform risky behaviours 55 
such as fighting and mating (Hosie and others 1989; Levy and others 2006; Malik and others 56 
1997). Adult cats have been identified as at greater risk of FeLV infection than juveniles (Levy 57 
and others 2006), however it has been suggested that a degree of age related immunity occurs, 58 
meaning that when infection does occur in later life, it may be more likely to be regressive 59 
(Hartmann 2012; Hoover and others 1976). Feral cats have been suggested to be at greater risk 60 
of FIV infection (Levy and others 2006), whilst cats from multicat households are at increased 61 
risk of FeLV infection (de Almeida and others 2012). It has been suggested that the prevalence 62 
of FeLV has decreased over recent years, possibly due to an increase in vaccination (Englert 63 
and others 2012; Hartmann 2012; Lutz and others 2009). Data for trends over time suggests that 64 
FIV prevalence has either remained stable or possibly dropped over the past 30 years at least in 65 
specific populations (Courchamp and others 1998; Friend and others 1990; Norris and others 66 
2007); however, definitive local trends are often difficult to identify, as there are relatively few 67 
studies repeated within the same population, and improvements in diagnostic tests over time 68 
limits comparison between them (Little 2011; Ravi and others 2010; Teixeira and others 2012) . 69 
Current trends in UK prevalence for both diseases are hard to establish as relatively few data are 70 
available, and none recent (Hosie and others 1989; Muirden 2002) 71 
Prevalence in owned cats varies widely across the world. Infection prevalence in stray and 72 
shelter cats has been shown in different studies to be both higher and lower than the 73 
corresponding pet cat populations (Hellard and others 2011a; Little and others 2009; Norris and 74 
others 2007). In the UK, a 2002 study at RSPCA Birmingham Animal Hospital (BAH, since re-75 
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named to BACH) identified 10.4% positive for FIV infection, and 3.5% for FeLV infection 76 
(Muirden 2002). Elsewhere, variable prevalences of 1.7% to 23% for FIV and 1.5% to 6.7% for 77 
FeLV have been reported in stray and shelter cats (Courchamp and others 1998; Levy and 78 
others 2006; Little 2005). This inconsistency may be partially due to differing strategies for 79 
selection of cats for testing in these populations (Levy and others 2006).It may also be possible 80 
that pockets of transmission occur within sub-populations, governed by localised risk factors 81 
such as neutering or vaccination.  82 
Many cat shelters perform FIV and/or FeLV testing on some or all of their animals, as part of 83 
health screening for the individual, population healthcare, and also to provide reassurance to 84 
prospective owners. These typically utilise patient-side tests which detect FIV antibody and FeLV 85 
antigen respectively.  FIV and FeLV infection have been shown to be one of the most common 86 
reasons for death or euthanasia in shelters (Murray and others 2008). However, if every one of 87 
the estimated 130,000 cats passing through rescue shelters in the UK annually (Stavisky and 88 
others 2012) was tested, this would add significantly to the cost of caring for and rehoming these 89 
animals. Additionally, when the patient-side test is used as a population screening tool, the 90 
relatively low population prevalence and subsequently low positive predictive value leads to 91 
difficulties in interpretation of the results. Cats which test positive for FeLV may undergo 92 
confirmatory tests such as PCR, and further tests to differentiate progressive from regressive 93 
infection, which incurs both a financial cost and potentially an extended stay in a rescue facility. It 94 
may therefore be desirable to establish known risk factors within this population of cats, in order 95 
to guide selection of cats for testing, to improve cost-effectiveness and accuracy of testing and 96 
expedite rehoming of cats. 97 
The aim of this study was to determine the prevalence of FeLV and FIV infection in cats 98 
presented to two charities in the UK, as determined by a patient-side test. A secondary aim was 99 
to identify risk factors for infection within the populations under study. 100 
Materials and Methods 101 
Shelters 102 
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The study was a retrospective case-control study, conducted at two charities. RSPCA 103 
Birmingham Animal Centre and Hospital (BACH; Shelter A) is a large charity hospital and 104 
rehoming centre in the midlands region of the UK. Block Fen RSPCA (Shelter B) is a rural animal 105 
rehoming centre in the east of England. Both organisations accept animals generated by RSPCA 106 
animal inspectors, which may be stray, injured or confiscated for welfare reasons. In addition, 107 
RSPCA BACH provides charitable veterinary care to owners with low incomes, and members of 108 
the public also present sick and injured stray animals. 109 
Study population 110 
The population included any unowned cat presented for admission to the shelters or hospital 111 
over the year August 2011-August 2012 that was tested for FIV/FeLV. Publicly-owned animals 112 
were excluded (ie those visiting for treatment at BAH). At both shelters, during the study period, 113 
the operating policy stated that every cat admitted was tested for FeLV/ FIV as soon after entry 114 
as practicable, with the exception of those cats euthanased for welfare reasons on entry, and 115 
kittens under 6 months (Shelter A) or under 4 months (Shelter B).  116 
All tests were carried out using either VetLab FASTest FeLV-FIV Combination Test (Shelter A) or 117 
IDEXX SNAP FeLV/ FIV Combo (Shelter B) patient-side tests, using anticoagulated whole blood 118 
(Shelter A) or separated serum (Shelter B). The SNAP Combo detects p27 antigen for FeLV 119 
(sensitivity 98.6%, specificity of 98.2%), and antibodies directed against p24 and gp40 for FIV 120 
(sensitivity 93.5%, specificity of 100%) (Hartmann and others 2007).. Similarly, the VetLab 121 
FASTest VetLab FASTtest detects p27 antigen for FeLV (sensitivity 95%, specificity 99%) and 122 
antibodies directed against gp40 for FIV (sensitivity 96%, specificity of 99%) (Vetlab_Supplies 123 
2012).  124 
Data collection 125 
Computerised clinical records for every cat presented at both shelters during the study period 126 
were extracted, along with estimated age, sex, neuter status (if known) and test result. Details of 127 
clinical presentation were extracted by manually searching the free text records. All information 128 
was stored using Microsoft Excel version 10. 129 
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Data cleaning 130 
Estimated age was provided at shelter A by calculating the difference between the date of 131 
consultation and the estimated date of birth on the record. Age was recorded in Shelter B in 132 
categories (0-3 months, >3-6 months, >6-9 months and yearly categories from then on), and 133 
therefore age from one year was treated as a categorical variable to ensure consistency within 134 
the dataset. For cats of < 1 year of age, interpolation was used to estimate age; for example cats 135 
assigned to the 3-6 month age group were nominally assigned an age of 137 days to enable 136 
comparison between the two data sets. 137 
Where neuter status was not directly recorded in patient records, description within the records 138 
such as “spay scar present” or “no uterus on surgery” were used to assign neuter status. Animals 139 
for which a neuter procedure was recorded subsequent to the test were assigned the status of 140 
entire, as were pregnant or lactating animals. Pregnancy or admission with a litter was also 141 
evaluated separately as a risk factor. 142 
In order to determine the health of each cat at the point of entry, the clinical notes for the first 143 
clinical consultation were interrogated by MM, from date of admission to up to three days after 144 
admission. Cats were considered healthy if “clinical exam NAD” (no abnormality detected) or 145 
similar phrasing was found.  Lack of recorded signs was treated as missing data. Each clinical 146 
sign recorded was categorised by body system (eg limb fracture would be coded as 147 
“musculoskeletal”). In order to investigate a link with feline upper respiratory tract disease (“cat 148 
flu”), a separate variable was created where free text mentioned “cat flu/ URTD”, or one or more 149 
of sneezing, ocular or nasal discharge. Similarly, “fight wounds” and “abscess(es)” were 150 
collapsed into a single category, as were “dental disease”, “gingivitis” and “stomatitis”. Body 151 
condition was dichotomised into “thin” (<3/5) or “not-thin” (≥3/5); again where body condition was 152 
not recorded this was treated as missing data. 153 
Case definition 154 
Any cat with a positive test result recorded for FeLV, FIV or both was treated as a case. Analysis 155 
for each disease was conducted separately; numbers of co-infected animals were too low for 156 
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meaningful statistical analysis. Kittens of under 3 months of age were excluded from analysis, 157 
due to a possible confounding effect from maternally derived antibodies to FIV (Ueland and 158 
Nesse 1992). 159 
Data analysis 160 
Analyses were carried out in Statistical Package for the Social Sciences (SPSS) Version 22. 161 
Continuous data such as age were non-normal and therefore described in terms of medians and 162 
interquartile ranges.  163 
Associations between each of the potential risk factors and FeLV and FIV test status was 164 
performed separately using univariable binomial regression. Factors with a p<0.2 in univariable 165 
analysis were considered for inclusion in a multivariable regression model, which was 166 
constructed using backwards elimination. Terms with a plausible biological association were 167 
tested for interaction and the most parsimonious model selected, using Pearson’s correlation to 168 
determine whether to include or reject terms with the appearance of correlation. Rejected terms 169 
were rechecked individually against the final model. Age (in days) was non-linear and therefore 170 
log-transformed. Goodness-of-fit was assessed using the Hosmer and Lemeshow test. 171 
Significance was set at p<0.05 throughout. 172 
Results 173 
Overall, data were obtained from a total of 726 cats, 523 from Shelter A, and 203 from Shelter B. 174 
Although the minimum age for testing differed between Shelter A and Shelter B, in practice, the 175 
majority of kittens of under 3 months from both shelters were not tested (41/57, 71.9%). Of the 176 
16 kittens aged under 3 months which were tested, all were from Shelter B, and one tested 177 
positive for FIV, and none for FeLV. The majority of kittens aged 3-6 months from both shelters 178 
were tested (35/44, 79.5%) for both FeLV and FIV. Therefore, 57 kittens aged under 3 months 179 
were excluded from the analysis, whilst kittens of 3-6 months were included.  The median age for 180 
Shelter A was 3 years (Interquartile range [IQR] 1, 5) , and for Shelter B was 3 years (IQR 1, 181 
6.5).Test results were missing from a further 60 cats (28 from Shelter A, 32 from Shelter B), 182 
giving a total of 609 cats in the final dataset, 474 from Shelter A, and 135 from Shelter B. Of 183 
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these, four cats cat had only an FIV result (of which one was positive), and no FeLV result 184 
recorded. Therefore the final dataset was 609 cats for FIV and 605 for FeLV (Table 1). 185 
 186 
 Number of cats (%) 
Shelter A Shelter B 
Sex Male 295 (62.2) 65 (48.1) 
 Female 169 (35.7) 70 (51.9) 
 Unknown/ not recorded 10 (2.1) 0 
Neuter status Neutered 61 (12.9) 5 (3.7) 
 Entire 313 (66) 61 (45.2) 
 Unknown/ not recorded 100 (21.1) 69 (51.1) 
FIV status Positive 54 (11.4) 4 (3) 
 Negative 420 (88.6) 131 (97) 
FeLV status Positive 14 (3) 0 
 Negative 459 (96.8) 132 (97.8) 
 Missing 1 (0.2) 3 (2.2) 
Table 1: Overall demographics and test results for cats from Shelter A and Shelter B 187 
     
Disease prevalence 188 
The overall prevalence of FIV was 9.5 % (95% CI 7.4-12.1%) and of FeLV was 2.3% (95% CI 189 
1.4-3.9). Cats at Shelter A were significantly more likely to be infected with FIV (p=0.0024) or 190 
FeLV (p=0.048) than cats at Shelter B. Two cats (both from Shelter A) were co-infected with FIV 191 
and FeLV. 192 
Age 193 
Cats that tested positive for FIV were significantly older than those that tested negative 194 
(p<0.001), with positive cats having a median age of 1864 days (5.1 years; 95% CI 1627-2101 195 
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days) as compared to 1244 days (3.4 years; 95% CI 1157-1131 days) for negative cats. 196 
Likewise, FeLV positive cats were significantly older than FeLV negative cats, with positive cats 197 
having a mean age of  1735 days (4.75 years; 95% CI 1273-2197), as compared to 1289 days 198 
(3.5 years; 95% CI 1204 – 1373 days) for FeLV negative cats (p=0.06). 199 
Univariable analysis 200 
Risk factors which were eligible for inclusion in the multivariable logistic regression model for FIV 201 
are shown in Table 2. 202 
 203 
Factor (reference category is 
disease absence) Significance Odds Ratio 
95% C.I. for Odds Ratio 
Lower Upper 
 Sex (Reference category female) <0.001 43.8 6.03 319.0 
Neurological signs .035 2.6 1.07 6.2 
Fight wounds/ abscess <0.001 5.8 3.1 10.7 
Cat flu .016 2.4 1.2 4.7 
Dental disease/ stomatitis .172 1.6 .8 3.2 
Fleas .138 1.8 .8 4.1 
Log age (days) <0.001 9.5 3.9 23.5 
Body condition (low or not-low) .177 1.8 .8 4.2 
Shelter <0.001 4.2 1.5 11.8 
Table 2: Risk factors for FIV infection from univariable analysis which were considered for 204 
inclusion in the multivariable analysis 205 
The final multivariable model for FIV suggested that male gender, clinical signs of cat flu and 206 
shelter were associated with an increased risk of infection. Increasing age was also associated 207 
with increased risk of positive test status (Table 3). Presence of fight wounds or abscesses was 208 
11 
 
considered for model inclusion but found to be strongly correlated with sex (Pearson correlation 209 
0.251, p< 0.001) and was therefore removed from the final model. 210 
 
Significance Odds ratio 
95% CI for odds ratio 
Lower Upper 
Sex (Reference category female) .001 27.1 3.7 199.1 
Shelter (Reference category 
Shelter B) 
0.009 4.3 1.4 12.6 
Log age (days) .000 8.2 2.7 24.6 
Table 3: Final multivariable model of risk factors for FIV test positive status. Nagelkerke R 211 
Square value 0.261, Hosmer and Lemeshow p=0.773 212 
Table 4 shows the factors from the univariable analysis which were eligible for the model for 213 
FeLV. The final multivariable model retained only thin body condition score and signs of 214 
musculoskeletal disease as risk factors for a positive FeLV test result (Table 5). 215 
Factor (reference category is 
disease absence) Significance Odds ratio 
95% CI for odds ratio 
Lower Upper 
Sex (Male = 1)* .382 1.7 .5 5.4 
Musculoskeletal disease .028 3.4 1.1 9.9 
Ocular disease .144 2.4 .7 7.9 
Body Condition .000 10.3 3.4 31.2 
Log age (days) .050 5.0 1.0 25.3 
Anaemia .008 8.8 1.8 44.0 
Table 4: Results of univariable analysis for FeLV test-positive status which were nominated for 216 
inclusion in the multivariable model. *Sex was not included in the model, but is shown here for 217 
comparison with FIV. Shelter could not be included as a variable, as there were no FeLV positive 218 
cats at Shelter B. 219 
 Significance Odds ratio 95% CI for odds ratio 
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Lower Upper 
Body condition (thin or not-thin) <0.001 11.8 3.8 37.1 
Musculoskeletal disease 0.016 4.0 1.3 12.5 
Table 5: Final multivariable model of risk factors for FeLV test positive status. Nagelkerke R 220 
Square value 0.157, Hosmer and Lemeshow p=0.916 221 
Discussion 222 
This study has shown a variable prevalence of FeLV and FIV in two populations of animals 223 
entering charity hospital and rehoming services. Despite the similar criteria for admission to 224 
these two sites, the difference in the disease prevalence in these two populations suggests there 225 
must be some critical distinctions between them. Both populations of cats consisted of those 226 
presented by RSPCA inspectors as stray, injured or confiscated for reasons of animal welfare, as 227 
well as some directly relinquished by owners (Shelter B only). It is possible that the proportions of 228 
these subcategories differed between the two shelters, or that factors such as inferred greater 229 
population density in the urban environment may have contributed to this variation in risk; cats 230 
from inner city environments have previously been found to be at increased risk of FIV infection 231 
(Malik and others 1997). Additionally, the proportion of male cats was higher in Shelter A than 232 
Shelter B (62.2% as compared with 48.1%), which could have also contributed to the higher 233 
prevalence of FIV. Although these specific results cannot be generalised across the whole feline 234 
population, the disparity between the prevalences found does reinforce the importance of 235 
knowledge of local patterns of infection when designing and administering a testing policy. 236 
Interestingly, the prevalence of both FeLV and FIV at RSPCA BACH seems to be remarkably 237 
similar to the prevalence revealed in 2002, in the same hospital, also using patient-side testing 238 
(Muirden 2002). It is uncertain why this may be the case, especially given that no FeLV positives 239 
were detected in Shelter B, but it is possible that factors such as vaccine coverage (for FeLV) 240 
and neutering rates could be implicated. Sub-populations of cats with limited engagement with 241 
veterinary care have been identified (Aegerter J. and others 2017), and it may be hypothesised 242 
that the BACH cats could be largely drawn from one such sub-population. 243 
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In terms of seropositivity to FIV, entire males are clearly at a much increased risk of infection, 244 
which agrees with previous studies (Courchamp and others 1998; Levy and others 2006).The 245 
additional link between FIV seropositivity and presence of fight wounds and abscesses supports 246 
the previously demonstrated relationship with behaviours associated with increased likelihood of 247 
transmission. FIV positive cats were significantly older than FIV-negative cats, and this is 248 
consistent with other studies suggesting that middle-aged cats are more commonly infected 249 
(Levy and others 2006; Spada and others 2012), due to cumulative risk of infection over time, or 250 
to the time taken to develop FIV-associated illness. In studies where the test is used for 251 
diagnosis rather than screening, the cats may be presented at an older age due to a delay 252 
between infection and development of clinical signs of sufficient severity to be presented for 253 
veterinary treatment. On univariable analysis, clinical signs consistent with cat flu were also 254 
associated with increased risk of FIV seropositivity, presumably due to immunosuppression in 255 
the presence of near-ubiquitous respiratory pathogens. This factor was eventually excluded from 256 
the multivariable model; however this may be worthy of further investigation, as an association 257 
with cat flu would agree with previous findings (Hosie and others 1989), and may be useful in 258 
guiding choices about which cats to test. 259 
For cats testing positive for FeLV, being thin on presentation (BCS<3/5) was significantly 260 
associated with infection (OR 11.8, 95% CI 3.8-37.1). Presence of musculoskeletal disease, such 261 
as lameness or fractures, was also identified as a risk factor (OR 4.0, 95% CI 1.3, 12.5) and 262 
again may reflect a link with risky behaviours such as roaming and fighting. Again, FeLV-positive 263 
cats were typically older than the remainder of the study population, with a mean age of 4.75 264 
years. Whilst a little older than FeLV-positive populations in previous studies, this finding is 265 
broadly consistent with previous data showing the highest FeLV prevalence to be in young to 266 
middle aged adults (de Almeida and others 2012; Gleich and others 2009a; Hellard and others 267 
2011b). However, the complex interplay of the risk of infection, a cat’s immune response and the 268 
curtailed lifespan of progressively infected cats make it difficult to generalise about the interaction 269 
between risk of FeLV infection and age on a population basis.  270 
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Limitations must be considered when interpreting these data. The results were collected over a 271 
year, from two shelters recruited on a convenience basis. Therefore, they may not be 272 
representative of all such organisations. Data were collected retrospectively, meaning that some 273 
information was missing. This may have caused an underestimation of prevalence, as animals 274 
sick enough to be euthanased without testing, soon after presentation, may have been at 275 
increased risk of infection. Similarly, missing data, either due to incomplete recording of test 276 
results or regarding specific clinical signs could have potentially affected study power, although 277 
the effect of this is difficult to quantify. Animal origin (stray, relinquished etc) was too 278 
inconsistently recorded to be included in the analysis. This incompleteness is reflected in the 279 
relatively low R2 values for both models, which suggests the importance of other, unmeasured 280 
factors is significant. 281 
The prevalence of FeLV in this study was low, limiting the statistical power to examine risk 282 
factors; a larger study would be required to more fully investigate the impact of risk factors. 283 
Finally, the combination of a relatively low population prevalence and imperfect test specificity 284 
could have led to some false positives, inflating the apparent FeLV prevalence.  However, 285 
without the use of PCR tests, regressive infections would have been missed, increasing 286 
uncertainty around the FeLV prevalence estimates. 287 
Conclusions 288 
These findings suggest that within the cats at BACH (Shelter A), neither FIV nor FeLV 289 
prevalence markedly changed over the ten years prior to data collection. This implies that factors 290 
such as FeLV vaccination and neutering coverage could be improved upon in this population of 291 
cats, although it is also important to note that in both populations, FeLV infection was relatively 292 
uncommon. Initiatives to improve feline welfare and control over-population have been instigated 293 
over recent years, including a move to prepubertal neutering and multi-agency approaches to 294 
engage hard-to-reach owners (Joyce and Yates 2011; Roberts and Clements 2015), and 295 
outcomes from such projects should be closely monitored to determine where resources can be 296 
used for maximum impact. In the study population, being male, presence of fight wounds and 297 
abscesses and clinical signs of cat flu were associated with seropositivity for FIV infection. Thin 298 
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body condition and signs of musculoskeletal disease were associated with increased risk of 299 
testing FeLV positive. These factors could be used to prioritise at-risk cats for testing, informing 300 
the use of FIV and FeLV tests within a charity context, to maximise test predictive value and 301 
improve efficient uses of resources to promote feline health and wellbeing. 302 
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